Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 2 1Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 6Uterine Cervical Neoplasms 2Rectal Neoplasms 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Multiple Myeloma 2Adenomatous Polyposis Coli 2Uterine Neoplasms 1Thrombocythemia, Essential 1Stomach Neoplasms 1Smoldering Multiple Myeloma 1Sezary Syndrome 1Radiodermatitis 1Prostate Cancer Metastatic Castration Resistant 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Pain 1Neoplasms 1Myelodysplastic Syndromes 1Mycosis Fungoides 1Monoclonal Gammopathy of Undetermined Significance 1Lymphoma, T-Cell, Cutaneous 1Leukemia, Lymphocytic, Chronic, B-Cell 1Head and Neck Neoplasms 1Gastritis, Atrophic 1Fatigue 1Endometrial Neoplasms 1Communicable Diseases 1Colorectal Neoplasms 1

Interventions

Gemcitabine 53Bevacizumab 52Cyclophosphamide 49Docetaxel 42Carboplatin 40pembrolizumab 37Paclitaxel 36Fluorouracil 36Cisplatin 35Radiotherapy 31Oxaliplatin 31Capecitabine 29Irinotecan 28Dexamethasone 27Leucovorin 25Cetuximab 25Nivolumab 24Doxorubicin 22Drug Therapy 21Erlotinib Hydrochloride 20Pemetrexed 19durvalumab 18trametinib 17fludarabine 16atezolizumab 16Trastuzumab 16Sunitinib 16Rituximab 16Prednisone 16Sorafenib 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Neoplasms × Curcumin × Clear all
NCT02944578 2024-10-29

Topical Curcumin for Precancer Cervical Lesions

Emory University

Phase 2 Terminated
7 enrolled 7 charts

Communicable Diseases, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡